Supplementary_Tables_1_and_2_042819 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts

Chen, Chun-Wei; Cheng, Jur-Shan; Chen, Tai-Di; Le, Puo-Hsien; Ku, Hsin-Ping; Chang, Ming-Ling

doi:10.25384/SAGE.8294990.v1

Supplementary_Tables_1_and_2_042819.doc (87 kB)

Supplementary_Tables_1_and_2_042819 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts

journal contribution

posted on 2019-06-17, 12:00 authored by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku, Ming-Ling Chang

Supplemental material, Supplementary_Tables_1_and_2_042819 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology